Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Pulmonary fibrosis is a feature of interstitial lung disease characterised by scarring of the lung parenchyma. It usually progresses and therefore has a poor prognosis. In approximately 20% of cases, disease clusters in families, but most cases occur sporadically with unknown cause. Two antifibrotic treatments are currently available but these are costly, have detrimental side effects and only slow disease progression. A greater understanding of what causes this dreadful disease would help patients and their families and enable screening and new treatments to be sought. Patients with pulmonary fibrosis have shorter average telomere length than similarly aged controls. In the majority of familial cases for whom causal genes have been found, disease causality has been attributed to heritable variants in telomere maintenance genes. Here a large population data set from the UK Biobank was analysed with Mendelian randomisation methodologies and replicated in clinical cohorts, to explore causality of telomere length in sporadic or idiopathic pulmonary fibrosis and compare that with chronic obstructive pulmonary disease (COPD), which has a similar patient demographic. Based on the results, the hypothesis that testosterone and oestrogen may protect against premature telomere shortening and hence pulmonary fibrosis disease onset and progression was studied using measured hormone levels and proxies in UK Biobank data. Finally, a clinical study of 102 pulmonary fibrosis patients was carried out via routine interstitial lung disease outpatient clinics to gather baseline data to support a future clinical treatment trial. Sex hormone concentrations, leukocyte telomere lengths and lung function data were measured and analysed. 93 patients were interviewed for detailed history. Age and sex matched control samples were used for comparison. Strong evidence of a causal relationship between short telomeres and idiopathic pulmonary fibrosis was shown and highlighted through comparison with the null association in COPD, in both UK Biobank data and respective replication cohorts. Strong and consistent links were found between depleted sex hormones, short telomeres and pulmonary fibrosis prevalence, with evidence of an interaction between sex hormones and genetic risk for short telomeres. From the clinical study, patients had shorter telomeres and lower sex hormone levels than matched controls, with reported symptoms of sex hormone depletion. Furthermore, associations were found between sex hormone levels and lung function measures. These findings provided evidence for the first time that prematurely short telomeres cause idiopathic pulmonary fibrosis. They also showed that depleted sex hormones associate with both short telomeres and disease symptoms. The implication is that hormone supplementation may protect against premature telomere attrition. Additional in vitro mechanistic analysis is recommended and a treatment study for pulmonary fibrosis patients may be warranted.
Author: A Duckworth
Institution: University of Exeter
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: idiopathic pulmonary fibrosis, telomere length, sex hormones, testosterone, estrogen, telomere shortening, chronic obstructive pulmonary disease, Mendelian randomization, causal inference, leukocyte telomere length, lung function, hormone supplementation, interstitial lung disease, familial pulmonary fibrosis, telomere maintenance genes, UK Biobank
Open Access status: green
Awards: G314022964, G7995088903
OpenAlex ID: W7033806167
